Ouma Shinji, Fukae Jiro, Fujioka Shinsuke, Yamamoto Shosaburo, Hatano Taku, Yoritaka Asako, Okuma Yasuyuki, Kashihara Ken-Ichi, Hattori Nobutaka, Tsuboi Yoshio
Department of Neurology, Fukuoka University School of Medicine, Japan.
Department of Neurology, Juntendo University School of Medicine, Japan.
Intern Med. 2017;56(15):1961-1966. doi: 10.2169/internalmedicine.56.7667. Epub 2017 Aug 1.
Objective Parkinson's disease (PD) is a common, progressive, neurodegenerative disorder. With progression of PD, the wearing-off phenomenon occurs more frequently as a motor complication, decreasing the patient's quality of life. The aim of this study was to investigate the risk factors for the wearing-off phenomenon in Japanese PD patients. Methods All of the study participants were clinically diagnosed as having PD. Each patient was assessed for the wearing-off phenomenon based on the findings of clinical assessments and interviews that were conducted during a single visit. The risk factors for wearing-off were analyzed by univariate and multivariate logistic regression analyses. Results Wearing-off was observed in 101 of the 180 (56.1%) patients who were enrolled in this study. The multivariate logistic regression analysis revealed that the onset of PD at ≥69 years of age (odds ratio [OR], 0.22; 95% confidence interval [CI], 0.05-0.88; p=0.032), female sex (OR, 6.49; 95% CI, 2.34-17.99; p<0.001), catechol-O-methyltransferase (COMT) inhibitor treatment (OR, 19.59; 95% CI, 3.55-108.11; p<0.001) and a high daily levodopa dosage (≥600 mg/day) (OR, 7.69; 95% CI, 1.41-41.84; p=0.018) were independent predictive factors for wearing-off in Japanese PD patients. Conclusion Age at the symptomatic disease onset, female sex, COMT inhibitor treatment, and a high daily levodopa dose were associated with the occurrence of wearing-off in Japanese PD patients. Physicians need to consider the risk factors and carefully choose medications for PD patients to postpone the occurrence of this phenomenon for as long as possible.
目的 帕金森病(PD)是一种常见的、进行性的神经退行性疾病。随着PD病情进展,剂末现象作为一种运动并发症更频繁地出现,降低了患者的生活质量。本研究旨在调查日本PD患者剂末现象的危险因素。方法 所有研究参与者均经临床诊断为患有PD。根据单次就诊期间进行的临床评估和访谈结果,对每位患者进行剂末现象评估。通过单因素和多因素逻辑回归分析来分析剂末现象的危险因素。结果 在本研究纳入的180例患者中,有101例(56.1%)出现剂末现象。多因素逻辑回归分析显示,69岁及以上发病(比值比[OR],0.22;95%置信区间[CI],0.05 - 0.88;p = 0.032)、女性(OR,6.49;95% CI,2.34 - 17.99;p < 0.001)、儿茶酚-O-甲基转移酶(COMT)抑制剂治疗(OR,19.59;95% CI,3.55 - 108.11;p < 0.001)以及每日左旋多巴高剂量(≥600 mg/天)(OR,7.69;95% CI,1.41 - 41.84;p = 0.018)是日本PD患者剂末现象的独立预测因素。结论 症状性疾病发病年龄、女性、COMT抑制剂治疗以及每日高剂量左旋多巴与日本PD患者剂末现象的发生有关。医生需要考虑这些危险因素,并为PD患者谨慎选择药物,以尽可能推迟这种现象的发生。